The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases
about
Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymesFormation of VEGF isoform-specific spatial distributions governing angiogenesis: computational analysisProteoglycan form and function: A comprehensive nomenclature of proteoglycansEndorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonismEndorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cellsEarly VEGFR2 activation in response to flow is VEGF-dependent and mediated by MMP activityHeparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney.Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivoMMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytesPerlecan domain IV peptide stimulates salivary gland cell assembly in vitroSuppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNAPerlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis.Matrix metalloproteinases: old dogs with new tricksThe role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagyInsidious changes in stromal matrix fuel cancer progressionExtracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.Matrix metalloproteinase 1: role in sarcoma biologyPlasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision MedicineExtracellular Matrix, a Hard Player in AngiogenesisMatrix metalloproteinases in inflammatory bowel disease: an updateFibroblast growth factor-binding protein is a novel partner for perlecan protein coreThe protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchorHeparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complicationsDevelopmental expression of perlecan during murine embryogenesisThe C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycansTranscriptional silencing of perlecan gene expression by interferon-gammaEssential contribution of tumor-derived perlecan to epidermal tumor growth and angiogenesisStructural and functional characterization of the human perlecan gene promoter. Transcriptional activation by transforming growth factor-beta via a nuclear factor 1-binding elementHeterotrimeric G protein-dependent WNT-5A signaling to ERK1/2 mediates distinct aspects of microglia proinflammatory transformationThe Role of PTEN in Tumor AngiogenesisWARP is a novel multimeric component of the chondrocyte pericellular matrix that interacts with perlecanMembrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinasesMatrix metalloproteinases and the regulation of tissue remodellingMultiscale models of angiogenesisHuman pancreatic precursor cells secrete FGF2 to stimulate clustering into hormone-expressing islet-like cell aggregatesExperimentally induced phonation increases matrix metalloproteinase-1 gene expression in normal rabbit vocal foldSca-1 expression is required for efficient remodeling of the extracellular matrix during skeletal muscle regeneration.A novel interaction between perlecan protein core and progranulin: potential effects on tumor growth.Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention.
P2860
Q21092901-29180F56-59A4-4144-A724-67B82845549AQ21202775-1F0D9BC4-315D-4D22-AF66-7B5FD2F4E988Q21710680-1F707028-E7AE-4781-AAE6-9D593277E79BQ24303934-5A391990-0DF5-4C53-86DD-728BD1C4CAAFQ24312922-208F3738-C169-4713-9E59-5A66D1FEC623Q24338434-C98B4731-ACAD-4BC2-984A-646C7A735393Q24540314-56648684-22CE-4313-AABF-221871CF3C4FQ24564477-AABCA44E-5330-47A6-AAAF-B10613D1CF92Q24628843-6CBEE4E6-F7CA-4837-9F57-D755D0E81F42Q24642832-201D3AA5-5A34-4197-9F70-6268F490C563Q24646731-2AB46544-FD53-4F91-9E54-1EF6ECDE2A8EQ24653433-84457E7E-975F-43FC-8AA6-20C8CE1FFB12Q24795980-6E7B8A0D-7E0A-4724-A839-8F467ED568DAQ26800258-B6530B42-5718-4502-B089-25D5AFA8215AQ26851261-442B8874-6CA5-41EF-8A01-02BD6915F994Q27000351-9D9F9B8F-0C24-493D-B1B9-4DDF5E6F05A2Q27315973-9620A2F6-E114-4D69-B4E6-C5156E992802Q28067626-884BFF0A-AEA1-4B98-8D8F-5C0DF11F214BQ28072886-72F596E8-2E8F-4736-8688-2C805120F4FFQ28080664-82A9CDB0-B168-4172-A04A-D11982CD8643Q28142123-347D6FB8-25E8-4F4E-A8CE-E35CCA3A6C37Q28145823-E7F0CFCE-3AFE-4D02-952F-21F794350E21Q28201679-D12ED47E-A464-4CEF-BBBB-4E69B72A6967Q28213716-D2EC60D2-DA47-4798-B358-C4D680128307Q28251854-644792FF-6D3B-4295-8F94-6A1100A98126Q28259215-5B781E62-E27C-404A-B779-60525BD69585Q28262244-8C42A8C4-0CCC-44E4-812F-BE87C591DDA4Q28294512-3274A44D-20C8-4AB9-84A6-628402636016Q28303522-971A2428-AA0F-48BC-8278-14E638373C49Q28389097-AA67C2A1-6242-4857-A487-BE57CC010BA1Q28391620-B4507BDE-E5F7-448B-B54B-27BD5EA9A222Q28512220-A3B49440-839E-48A5-9222-C847F5DE781AQ28611036-67B12ED3-453C-44D8-955C-013B21939AAEQ29618747-EF6CC492-1C6B-4CBC-AF4B-5D633CFD00CCQ30432668-145953CF-A69F-48CA-9244-ADD36E38AC40Q30478349-76CB1206-E05F-4CF7-9B92-4D1A233B3600Q30480340-32B5949C-6442-4BC6-B25F-2F88C13CBAEEQ30486622-9E539E54-97E9-4C34-A1DE-FF8657221076Q33292070-9D8827B5-88B1-4D84-9206-9BBCA9075222Q33606833-0794CBB3-C00E-496E-A697-8A20DE78E819
P2860
The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases
description
1996 nî lūn-bûn
@nan
1996 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
The degradation of human endot ...... nase, plasmin, and heparanases
@ast
The degradation of human endot ...... nase, plasmin, and heparanases
@en
The degradation of human endot ...... nase, plasmin, and heparanases
@nl
type
label
The degradation of human endot ...... nase, plasmin, and heparanases
@ast
The degradation of human endot ...... nase, plasmin, and heparanases
@en
The degradation of human endot ...... nase, plasmin, and heparanases
@nl
prefLabel
The degradation of human endot ...... nase, plasmin, and heparanases
@ast
The degradation of human endot ...... nase, plasmin, and heparanases
@en
The degradation of human endot ...... nase, plasmin, and heparanases
@nl
P2093
P2860
P3181
P356
P1476
The degradation of human endot ...... nase, plasmin, and heparanases
@en
P2093
A D Murdoch
J M Whitelock
P A Underwood
P2860
P304
10079-10086
P3181
P356
10.1074/JBC.271.17.10079
P407
P577
1996-04-01T00:00:00Z